Establishing Mobile Transcranial Magnetic Stimulation
In this pilot study, investigators propose to design and create a portable TMS unit, in a van, and then test out delivering TMS in three different locations in South Carolina, all affiliated with MUSC and within 2-hours driving from Charleston, SC. This study would test out this new delivery mode, and provide valuable feasibility, safety, and efficacy lessons for later refinement and potential widespread adoption of mobile TMS as a treatment option, both in our state and across the US.
Conditions studied
Treatment Resistant Major Depression
About this study
In this pilot study, investigators propose to design and create a portable TMS unit, in a van, and then test out delivering TMS in three different locations in South Carolina, all affiliated with MUSC and within 2-hours driving from Charleston, SC. This study would test out this new delivery mode, and provide valuable feasibility, safety, and efficacy lessons for later refinement and potential widespread adoption of mobile TMS as a treatment option, both in our state and across the US.
Interventions
- Device: Left prefrontal Transcranial Magnetic Stimulation (TMS) — FDA cleared TMS
- Device: FDA cleared TMS for treating depression — This is FDA approved TMS
Primary outcomes
- Percent of depression responders (From baseline to 1 week immediately after treatment week)
- Improvement in Depression Symptoms (From baseline to 1 week immediately after treatment week)
Eligibility information
Study locations
- Medical Univerity of South Carolina, Charleston, South Carolina 29425 United States
Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.